Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENO Lime in Ajeerna Vyadhi (Acidity and Indigestion)
NCT07140341Phase 3Completed
- Sponsor
- Haleon
- Start
- Aug 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ENO Lime in dyspepsia, gastroesophageal reflux disease (GERD), nausea ((none)), sponsored by Haleon. Started Aug 2025; status: completed.
02
Drugs
ENO Lime
03
Conditions
dyspepsiagastroesophageal reflux disease (GERD)nausea ((none))
Beyond the preview
Go deeper on NCT07140341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07140341.